U. G. Ahlfors

2.7k total citations · 1 hit paper
29 papers, 2.2k citations indexed

About

U. G. Ahlfors is a scholar working on Psychiatry and Mental health, Pharmacology and Biological Psychiatry. According to data from OpenAlex, U. G. Ahlfors has authored 29 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 10 papers in Pharmacology and 5 papers in Biological Psychiatry. Recurrent topics in U. G. Ahlfors's work include Treatment of Major Depression (9 papers), Schizophrenia research and treatment (9 papers) and Bipolar Disorder and Treatment (8 papers). U. G. Ahlfors is often cited by papers focused on Treatment of Major Depression (9 papers), Schizophrenia research and treatment (9 papers) and Bipolar Disorder and Treatment (8 papers). U. G. Ahlfors collaborates with scholars based in Denmark, Finland and Sweden. U. G. Ahlfors's co-authors include S. J. Dencker, K. Elgen, Per Bech, Ole Christian Lingjærde, Jouko Tuomisto, Erkki Tukiainen, Tommy Lewander, Ulrik Fredrik Malt, Henrik Lublin and Eva Lindström and has published in prestigious journals such as The Lancet, Psychopharmacology and Acta Psychiatrica Scandinavica.

In The Last Decade

U. G. Ahlfors

27 papers receiving 2.0k citations

Hit Papers

The UKU side effect rating scale: A new comprehensive rat... 1987 2026 2000 2013 1987 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U. G. Ahlfors Denmark 16 1.5k 618 363 274 256 29 2.2k
S. J. Dencker Sweden 20 1.9k 1.3× 625 1.0× 502 1.4× 275 1.0× 233 0.9× 70 2.7k
M. W. P. Carney United Kingdom 22 1.1k 0.8× 728 1.2× 347 1.0× 375 1.4× 261 1.0× 75 3.0k
Ronald R. Fieve United States 33 1.9k 1.3× 427 0.7× 722 2.0× 420 1.5× 203 0.8× 92 3.1k
Richard L. Borison United States 27 1.1k 0.7× 385 0.6× 332 0.9× 165 0.6× 547 2.1× 66 1.9k
G Chouinard Canada 30 1.6k 1.1× 702 1.1× 631 1.7× 601 2.2× 514 2.0× 99 2.9k
Pierre V. Trân United States 17 1.5k 1.0× 616 1.0× 297 0.8× 175 0.6× 174 0.7× 28 1.9k
Hans‐Jürgen Möller Germany 23 1.2k 0.8× 467 0.8× 657 1.8× 390 1.4× 302 1.2× 65 2.6k
J M Perel United States 21 707 0.5× 654 1.1× 406 1.1× 309 1.1× 242 0.9× 39 1.8k
James L. Claghorn United States 21 831 0.6× 506 0.8× 476 1.3× 355 1.3× 221 0.9× 70 1.7k
Paul J. Goodnick United States 31 1.4k 1.0× 777 1.3× 474 1.3× 332 1.2× 369 1.4× 91 3.2k

Countries citing papers authored by U. G. Ahlfors

Since Specialization
Citations

This map shows the geographic impact of U. G. Ahlfors's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. G. Ahlfors with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. G. Ahlfors more than expected).

Fields of papers citing papers by U. G. Ahlfors

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. G. Ahlfors. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. G. Ahlfors. The network helps show where U. G. Ahlfors may publish in the future.

Co-authorship network of co-authors of U. G. Ahlfors

This figure shows the co-authorship network connecting the top 25 collaborators of U. G. Ahlfors. A scholar is included among the top collaborators of U. G. Ahlfors based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. G. Ahlfors. U. G. Ahlfors is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lindström, Eva, Tommy Lewander, Ulf Malm, et al.. (2002). UKU-SERS-Pat - the UKU side effect self-rating scale. European Psychiatry. 17. 193–193. 2 indexed citations
2.
Lindström, Eva, Tommy Lewander, Ulf Malm, et al.. (2001). Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat). Nordic Journal of Psychiatry. 55(sup44). 5–69. 28 indexed citations
3.
Lindström, Eva, Tommy Lewander, Ulf Malm, et al.. (2001). Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia: Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat). Nordic Journal of Psychiatry. 55(5). 5–69. 94 indexed citations
4.
Ahlfors, U. G., Tommy Lewander, Eva Lindström, et al.. (2001). Assessment of patient satisfaction with psychiatric care: Development and clinical evaluation of a brief consumer satisfaction rating scale (UKU-ConSat). Nordic Journal of Psychiatry. 55(5). 71–90. 15 indexed citations
5.
Ahlfors, U. G., Tommy Lewander, Eva Lindström, et al.. (2001). Assessment of patient satisfaction with psychiatric care. Nordic Journal of Psychiatry. 55(sup44). 71–90. 3 indexed citations
6.
Marttila, M., et al.. (1995). A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression. European Neuropsychopharmacology. 5(4). 441–446. 47 indexed citations
7.
Bech, Per, Ulrik Fredrik Malt, S. J. Dencker, et al.. (1993). Preface. Acta Psychiatrica Scandinavica. 87(S372). 3–3. 125 indexed citations
8.
Ahlfors, U. G., Björn Appelberg, Heikki Katila, et al.. (1990). Remoxipride and haloperidol in schizophrenia: a double‐blind multicentre study.. Acta Psychiatrica Scandinavica. 82(S358). 99–103. 20 indexed citations
9.
Amdisen, A., Mette Nielsen, S. J. Dencker, et al.. (1987). Zuclopenthixol acetate in Viscoleo® ‐ a new drug formulation. Acta Psychiatrica Scandinavica. 75(1). 99–107. 19 indexed citations
10.
Dencker, S. J., et al.. (1982). Nomifensine and Imipramine in Endogenous Depression. International Pharmacopsychiatry. 17(S1). 116–144. 4 indexed citations
11.
Ahlfors, U. G., P. C. Baastrup, S. J. Dencker, et al.. (1981). Flupenthixol decanoate in recurrent manic‐depressive illness. Acta Psychiatrica Scandinavica. 64(3). 226–237. 109 indexed citations
12.
Liewendahl, K., et al.. (1980). Effect of anticonvulsant and antidepressant drugs on iodothyronines in serum. Scandinavian Journal of Clinical and Laboratory Investigation. 40(8). 767–774. 15 indexed citations
13.
Ahlfors, U. G., et al.. (1980). Clopenthixol decanoate and perhenazine enanthate in schizophrenic patients: A DOUBLE‐BLIND NORDIC MULTICENTRE TRIAL. Acta Psychiatrica Scandinavica. 61(S279). 77–91. 26 indexed citations
14.
Tuomisto, Jouko, Erkki Tukiainen, & U. G. Ahlfors. (1979). Decreased uptake of 5-hydroxytryptamine in blood platelets from patients with endogenous depression. Psychopharmacology. 65(2). 141–147. 156 indexed citations
15.
Ahlfors, U. G., et al.. (1979). Symptom reduction in depression after treatment with L‐tryptophan or imipramine. Acta Psychiatrica Scandinavica. 60(3). 287–294. 16 indexed citations
16.
Fruensgaard, K, et al.. (1975). TRYPTOPHAN/IMIPRAMINE IN DEPRESSION. The Lancet. 306(7941). 920–920. 25 indexed citations
17.
Ahlfors, U. G.. (1974). Tväranalys Av Ett Kontrollerat Försök Med Pipotiazin-Undecylenat Och Flufenazinenantat. Nordisk Psykiatrisk Tidsskrift. 28(6). 459–461. 1 indexed citations
18.
Ahlfors, U. G., et al.. (1973). Effekten av piracetam vid akuta alkoholintoxikationer En dubbel-blind klinisk värdering av ett psykofarmakon av ny typ (UCB 6215, Nootropil®, Nootropyl®). Nordisk Psykiatrisk Tidsskrift. 27(7). 504–509. 1 indexed citations
19.
Ahlfors, U. G., et al.. (1973). CLINICAL EVALUATION OF A NEW DEPOT NEUROLEPTIC: A pilot study with pipotiazine undecylenate (19.551 R.P.). Acta Psychiatrica Scandinavica. 49(S241). 43–49. 3 indexed citations
20.
Ahlfors, U. G.. (1973). THREE YEARS OF CLINICAL EXPERIENCES WITH PIPOTIAZINE. Acta Psychiatrica Scandinavica. 49(s243). 40–41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026